To delineate potential pathways whereby the inactivation of Notch4 leads to preferable outcome in PDAC, we performed RNA-seq analysis between primary pancreatic cancer cell lines established from the pancreatic tumors developed in the PKC and the N4−/−PKC GEMMs. The gene discussed is NOTCH4; the disease is familial pancreatic carcinoma.